ARCHIVES

Cell Genesys Begins Phase II Trial Of Gvax Vaccine For Pancreatic Cancer.

This article is from The Cancer Letter archive.

Vol. 27 No. 44 | November 30, 2001

Download PDF Visit The Full Archive

Related Articles

Avastin Loses Indication for Breast Cancer

November 18, 2011

DCPC Board Commits More Than $100 Million To 15-Year Trial Of Low Fat Diet In Women

October 26, 1990

Cancer Policy; Cost Containment Impedes Research, Cancer Panel Finds

October 17, 1997

Komen Foundation Shifts Emphasis To Underserved

May 7, 1993

Selumetinib Displays Positive Results, 60% with Stable Disease

April 29, 2011

NCAB, Panel May Look A Discrepancies, In Study Section Evaluation Of Grant Applications

September 4, 1981